Bristol-Myers Squibb Company
Healthcare · Drug Manufacturers - General · $116B market cap · Ranked #552 of 1,207
Sits near the middle of the universe on the composite score. Ranks in the 54th percentile overall.
Figures come straight from the company’s filed quarterly report and feed the six-factor model (growth, quality, and value especially). This is a summary of what was reported — research, not a recommendation, and there are no analyst estimates behind it, so it isn’t a beat-or-miss call.
The latest raw values feeding the six factors.
Every rating we’ve ever assigned BMY — append-only and hash-verified. We don’t revise or delete past calls.
1 rating change across 103 snapshots — each with the factor shift that drove it.
The full append-only record of every call we’ve made on BMY— the accountability history mainstream sites quietly edit and we can’t — is part of Proofstock Plus.
Unlock with Plus